{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:28:33Z","timestamp":1789777713508,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Department of Science and Technology of Sichuan Province","award":["2025NSFJQ0057"],"award-info":[{"award-number":["2025NSFJQ0057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10072-026-09023-2","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:57:53Z","timestamp":1775782673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elimination of senescent cells fails to attenuate disease progression in an ALS mouse model"],"prefix":"10.1007","volume":"47","author":[{"given":"Lisha","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3947-9755","authenticated-orcid":false,"given":"Jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"9023_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2021.04.013","volume":"105","author":"G Margarita","year":"2021","unstructured":"Margarita G, Benjamin H, Ryan W et al (2021) Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts. Neurobiol Aging 105:64\u201377. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.04.013","journal-title":"Neurobiol Aging"},{"issue":"1","key":"9023_CR2","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/s41467-024-47758-8","volume":"15","author":"T Stanislav","year":"2024","unstructured":"Stanislav T, Kelsey V, Velina K et al (2024) Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls. Nat Commun 15(1):3606. https:\/\/doi.org\/10.1038\/s41467-024-47758-8","journal-title":"Nat Commun"},{"issue":"7","key":"9023_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4155\/cli.14.52","volume":"4","author":"P Sabrina","year":"2014","unstructured":"Sabrina P, Merit C, D B J (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clin Invest 4(7):605\u2013618. https:\/\/doi.org\/10.4155\/cli.14.52","journal-title":"Clin Invest"},{"issue":"1","key":"9023_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/clpt.2012.193","volume":"93","author":"MNR J B D","year":"2013","unstructured":"J B D MNR, M V D J (2013) Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther 93(1):105\u2013116. https:\/\/doi.org\/10.1038\/clpt.2012.193","journal-title":"Clin Pharmacol Ther"},{"issue":"21","key":"9023_CR5","doi-asserted-by":"publisher","first-page":"12078","DOI":"10.3390\/ijms222112078","volume":"22","author":"M Alexandra","year":"2021","unstructured":"Alexandra M, Michael LWE K (2021) Senolytics: A Novel Strategy for Neuroprotection in ALS? Int J Mol Sci 22(21):12078. https:\/\/doi.org\/10.3390\/ijms222112078","journal-title":"Int J Mol Sci"},{"issue":"20","key":"9023_CR6","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.3390\/ijms222011224","volume":"22","author":"B Thibaut","year":"2021","unstructured":"Thibaut B, Elisabeth R, Matthieu M et al (2021) Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis. Int J Mol Sci 22(20):11224. https:\/\/doi.org\/10.3390\/ijms222011224","journal-title":"Int J Mol Sci"},{"issue":"34","key":"9023_CR7","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","volume":"25","author":"S Burkhard","year":"2005","unstructured":"Burkhard S, Jens R, Lucia D-O et al (2005) The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J neuroscience: official J Soc Neurosci 25(34):7805\u20137812. https:\/\/doi.org\/10.1523\/JNEUROSCI.2038-05.2005","journal-title":"J neuroscience: official J Soc Neurosci"},{"issue":"2","key":"9023_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JND-140068","volume":"2","author":"SR Pfohl","year":"2015","unstructured":"Pfohl SR, Halicek MT, Mitchell CS (2015) Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis. J Neuromuscul Dis 2(2):137\u2013150. https:\/\/doi.org\/10.3233\/JND-140068","journal-title":"J Neuromuscul Dis"},{"key":"9023_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2019.00042","volume":"11","author":"T Emiliano","year":"2019","unstructured":"Emiliano T, R B P, Mari\u00e1ngeles K et al (2019) Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS. Front Aging Neurosci 11:42. https:\/\/doi.org\/10.3389\/fnagi.2019.00042","journal-title":"Front Aging Neurosci"},{"issue":"7814","key":"9023_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J et al (2020) Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583(7814):1\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2403-9","journal-title":"Nature"},{"issue":"7","key":"9023_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s43587-022-00250-8","volume":"2","author":"Z Xu","year":"2022","unstructured":"Xu Z, Leena H, Zaira A et al (2022) Characterization of cellular senescence in aging skeletal muscle. Nat Aging 2(7):601\u2013615. https:\/\/doi.org\/10.1038\/s43587-022-00250-8","journal-title":"Nat Aging"},{"key":"9023_CR12","doi-asserted-by":"publisher","unstructured":"Dong Y, Bin S, Shirong L et al (2023) NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Sci Transl Med 15(709). eadd1951-eadd https:\/\/doi.org\/10.1126\/scitranslmed.add1951","DOI":"10.1126\/scitranslmed.add1951"},{"issue":"1","key":"9023_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41420-024-01976-7","volume":"10","author":"Y Deng","year":"2024","unstructured":"Deng Y, Kumar A, Xie K, Schaaf K, Scifo E, Morsy S, Li T, Ehninger A, Bano D, Ehninger D (2024) Targeting senescent cells with NKG2D-CAR T cells. Cell death discovery 10(1):217. https:\/\/doi.org\/10.1038\/s41420-024-01976-7","journal-title":"Cell death discovery"},{"key":"9023_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo S, Cocozza G, Porzia A et al (2020) Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nat Commun 11:1773. https:\/\/doi.org\/10.1038\/s41467-020-15644-8","journal-title":"Nat Commun"},{"key":"9023_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/OTT.S341179","volume":"16","author":"M John","year":"2023","unstructured":"John M (2023) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. OncoTargets therapy 16:515\u2013532. https:\/\/doi.org\/10.2147\/OTT.S341179","journal-title":"OncoTargets therapy"},{"issue":"2","key":"9023_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/scitranslmed.add1951","volume":"11","author":"M Renzo","year":"2014","unstructured":"Renzo M, Jaume DV, Laura M et al (2014) Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics: J Am Soc Experimental Neurother 11(2):419\u2013432. https:\/\/doi.org\/10.1126\/scitranslmed.add1951","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"key":"9023_CR17","doi-asserted-by":"publisher","first-page":"1596499","DOI":"10.3389\/fimmu.2025.1596499","volume":"16","author":"S Yaacoub","year":"2025","unstructured":"Yaacoub S, Vannoy E, Maslova S et al (2025) CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence. Front Immunol 16:1596499. https:\/\/doi.org\/10.3389\/fimmu.2025.1596499","journal-title":"Front Immunol"},{"issue":"2","key":"9023_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1249\/MSS.0000000000002929","volume":"203","author":"L Wen","year":"2007","unstructured":"Wen L, Danielle B, Yanchun P et al (2007) Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 203(2):457\u2013471. https:\/\/doi.org\/10.1249\/MSS.0000000000002929","journal-title":"Exp Neurol"},{"issue":"5","key":"9023_CR19","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.isci.2020.101087","volume":"23","author":"DOB Rome","year":"2020","unstructured":"University of Rome Tor Vergata, Rome DOB, Italy IRCCS, Fondazione Santa Lucia R, Italy IRCCS, Fondazione Santa Lucia R, Italy et al (2020) Skeletal-muscle metabolic reprogramming in ALS-SOD1 G93A mice predates disease onset and is a promising therapeutic target. iScience 23(5):101087. https:\/\/doi.org\/10.1016\/j.isci.2020.101087","journal-title":"iScience"},{"issue":"4","key":"9023_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jnr.22242","volume":"88","author":"S Yosuke","year":"2010","unstructured":"Yosuke S, Kunio K, Yoshihiro N et al (2010) Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis. J Neurosci Res 88(4):896\u2013904. https:\/\/doi.org\/10.1002\/jnr.22242","journal-title":"J Neurosci Res"},{"key":"9023_CR21","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.1085","author":"D Zhou","year":"2024","unstructured":"Zhou D, Lin Y, Han Z et al (2024) The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives. Aging disease. https:\/\/doi.org\/10.14336\/AD.2024.1085","journal-title":"Aging disease"},{"issue":"15","key":"9023_CR22","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.7150\/thno.56070","volume":"11","author":"L Xiao","year":"2021","unstructured":"Xiao L, Chongyang C, Xu Z et al (2021) R13 preserves motor performance in SOD1G93A mice by improving mitochondrial function. Theranostics 11(15):7294\u20137307. https:\/\/doi.org\/10.7150\/thno.56070","journal-title":"Theranostics"},{"issue":"19","key":"9023_CR23","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.3390\/ijms221910305","volume":"22","author":"F Agueda","year":"2021","unstructured":"Agueda F, Ana C, M. F L, et al (2021) Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). Int J Mol Sci 22(19):10305. https:\/\/doi.org\/10.3390\/ijms221910305","journal-title":"Int J Mol Sci"},{"issue":"11","key":"9023_CR24","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.3390\/ijms23116217","volume":"23","author":"KPM Daniela","year":"2022","unstructured":"Daniela KPM (2022) Blood\u2013Brain Barrier Dysfunction and Astrocyte Senescence as Reciprocal Drivers of Neuropathology in Aging. Int J Mol Sci 23(11):6217. https:\/\/doi.org\/10.3390\/ijms23116217","journal-title":"Int J Mol Sci"},{"key":"9023_CR25","doi-asserted-by":"publisher","unstructured":"Sareen D, O\u2019rourke JG, Meera P et al (2013) Targeting RNA Foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5(208). https:\/\/doi.org\/10.1126\/scitranslmed.3007529","DOI":"10.1126\/scitranslmed.3007529"},{"issue":"12","key":"9023_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"MMTECM Angela","year":"2022","unstructured":"Angela MMTECM G et al (2022) Trial of Antisense Oligonucleotide Tofersen forSOD1ALS. N Engl J Med 387(12):1099\u20131110. https:\/\/doi.org\/10.1056\/NEJMoa2204705","journal-title":"N Engl J Med"},{"key":"9023_CR27","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0630-1","author":"Z Yumeng","year":"2023","unstructured":"Yumeng Z, Shouyue H, BING X et al (2023) Aging, Cellular Senescence, and Glaucoma. Aging disease. https:\/\/doi.org\/10.14336\/AD.2023.0630-1","journal-title":"Aging disease"},{"key":"9023_CR28","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0720","author":"J Xiao","year":"2024","unstructured":"Xiao J, LI HS, Satyanarayanan SK et al (2024) Advancements in Targeting Macrophage Senescence for Age-Associated Conditions. Aging disease. https:\/\/doi.org\/10.14336\/AD.2024.0720","journal-title":"Aging disease"},{"key":"9023_CR29","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3389\/fimmu.2019.01768","volume":"10","author":"F Salani","year":"2019","unstructured":"Salani F, Sterbini V, Sacchinelli E et al (2019) Is Innate Memory a Double-Edge Sword in Alzheimer\u2019s Disease? A Reappraisal of New Concepts and Old Data. Front Immunol 10:1768. https:\/\/doi.org\/10.3389\/fimmu.2019.01768","journal-title":"Front Immunol"},{"issue":"12","key":"9023_CR30","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/cells9122550","volume":"9","author":"C Roxane","year":"2020","unstructured":"Roxane C, Franck A, Philippe G et al (2020) How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis. Cells 9(12):2550. https:\/\/doi.org\/10.3390\/cells9122550","journal-title":"Cells"},{"issue":"1","key":"9023_CR31","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1038\/s41598-025-94984-1","volume":"15","author":"C Simonini","year":"2025","unstructured":"Simonini C, Zucchi E, Martinelli I et al (2025) Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen. Sci Rep 15(1):11034. https:\/\/doi.org\/10.1038\/s41598-025-94984-1","journal-title":"Sci Rep"},{"issue":"12","key":"9023_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.14348\/molcells.2019.0298","volume":"08826","author":"Seoul","year":"2019","unstructured":"School of Biological Sciences S N U, Seoul (2019) Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases. Mol Cells 08826(12):821\u2013827. https:\/\/doi.org\/10.14348\/molcells.2019.0298","journal-title":"Mol Cells"},{"key":"9023_CR33","doi-asserted-by":"publisher","first-page":"105612","DOI":"10.1016\/j.ebiom.2025.105612","volume":"113","author":"CL Millar","year":"2025","unstructured":"Millar CL, Iloputaife I, Baldyga K et al (2025) A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer\u2019s disease. EBioMedicine 113:105612. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105612","journal-title":"EBioMedicine"},{"issue":"3","key":"9023_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2022.12.JNS221285","volume":"139","author":"W Weijun","year":"2023","unstructured":"Weijun W, Haiping H, Shan Z et al (2023) Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies. J Neurosurg 139(3):1\u20139. https:\/\/doi.org\/10.3171\/2022.12.JNS221285","journal-title":"J Neurosurg"},{"issue":"prepublish","key":"9023_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.omto.2020.05.013","volume":"18","author":"K Tanaka","year":"2020","unstructured":"Tanaka K, Kato I, Tanaka M et al (2020) Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model. Mol Therapy - Oncolytics 18(prepublish):37\u201346. https:\/\/doi.org\/10.1016\/j.omto.2020.05.013","journal-title":"Mol Therapy - Oncolytics"},{"key":"9023_CR36","doi-asserted-by":"publisher","unstructured":"Wang X, Huynh C, Urak R, Weng L et al (2020) The cerebroventricular environment modifies CAR T cells for potent activity against both central nervous system and systemic lymphoma. Cancer Immunol Res 9(1). https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0236","DOI":"10.1158\/2326-6066.CIR-20-0236"},{"key":"9023_CR37","doi-asserted-by":"publisher","first-page":"814633","DOI":"10.3389\/fpsyg.2022.814633","volume":"13","author":"MHAWAJ A. D G P","year":"2022","unstructured":"A. D G P MHAWAJ et al (2022) Acute Effects of High-Intensity Aerobic Exercise on Motor Cortical Excitability and Inhibition in Sedentary Adults. Front Psychol 13:814633. https:\/\/doi.org\/10.3389\/fpsyg.2022.814633","journal-title":"Front Psychol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09023-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09023-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09023-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:31:04Z","timestamp":1778308264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09023-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["9023"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09023-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Animal Ethics Committee of West China Hospital, Sichuan University (ID: 20230203001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"411"}}